UNIVERSITY OF EXETER
Clinical Trials
132
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (99 trials with phase data)• Click on a phase to view related trials
Zithandani Stepping Stones and Creating Futures - Phase 2 Pilot
- Conditions
- Intimate Partner Violence (IPV)Earning OutcomesMental HealthCouple CommunicationCouple ConflictCouplesLivelihoods
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- University of Exeter
- Target Recruit Count
- 100
- Registration Number
- NCT06975137
- Locations
- 🇿🇦
South African Medical Research Council, Durban, South Africa
The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults
- Conditions
- Malnutrition ElderlyProtein Malnutrition
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- University of Exeter
- Target Recruit Count
- 20
- Registration Number
- NCT06965699
- Locations
- 🇬🇧
University of Exeter, Exeter, Devon, United Kingdom
Development of a Novel Screening Tool for Anosognosia After Stroke.
- Conditions
- AnosognosiaStroke
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- University of Exeter
- Target Recruit Count
- 90
- Registration Number
- NCT06940882
Short-term Effect of Using Non-immersive Gamified Exercises on Chronic Pain in People With Stroke.
- Conditions
- Stroke Patients
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- University of Exeter
- Target Recruit Count
- 30
- Registration Number
- NCT06863649
- Locations
- 🇬🇧
Vsimulator, Exeter, Devon, United Kingdom
The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adults.
- Conditions
- Nutritional Intervention
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- University of Exeter
- Target Recruit Count
- 15
- Registration Number
- NCT06852547
- Locations
- 🇬🇧
Health and Life Sciences, Exeter, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 26
- Next
News
Mindfulness-Based Cognitive Therapy Shows Promise for Treatment-Resistant Depression
A new clinical trial published in Lancet Psychiatry demonstrates that mindfulness-based cognitive therapy (MBCT) significantly improves symptoms in patients with difficult-to-treat depression compared to standard care.
Medicines Discovery Catapult Expands Strategic Partnerships to Accelerate UK Drug Discovery Innovation
Medicines Discovery Catapult has formed two major strategic partnerships with the Francis Crick Institute and University of Exeter to accelerate drug discovery and translational research across the UK.
Anti-Inflammatory Drugs and Infection Control May Reduce Dementia Risk, Studies Suggest
Recent evidence reviews indicate that controlling infections through vaccines, antibiotics, and antivirals may significantly reduce dementia risk, supporting theories linking infectious causes to common dementias.
UK Launches First Anti-Viral Drug Trial for Long COVID Treatment
Researchers from the University of Derby and Plymouth have initiated the UK's first anti-viral drug trial for long COVID, testing medication previously used only for hospitalized COVID-19 patients.
Phase 2 Trial Assesses 99mTc-maraciclatide for ILD Prognosis
A Phase 2 study, PREDICT-ILD, has commenced to evaluate 99mTc-maraciclatide, a novel molecular imaging agent, for predicting interstitial lung disease (ILD) progression.